Lauren Riker, Senior Vice President, Finance at Pacira BioSciences, Inc. (PCRX), sold 7,940 shares at $28.72 ($228K) on 2024-06-12, disclosed to the SEC on 2024-06-13.
Scheduled sale ($228k) by Senior Vice President, Finance under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.72 | 3,970 | $114K | 50.0% |
| 2 | $28.72 | 3,970 | $114K | 50.0% |
| Total | $28.72 avg | 7,940 | $228K | 100% |
| Filing → |
| PCRX | SELL | 2026-02-03 | $83K | — | Filing → |
| PCRX | SELL | 2026-01-06 | $34K | — | Filing → |
| PCRX | SELL | 2025-06-05 | $292K | — | Filing → |